Cardlytics Inc (NASDAQ:CDLX) Major Shareholder Sells $2,562,000.00 in Stock

Cardlytics Inc (NASDAQ:CDLX) major shareholder Polaris Venture Management Co. sold 100,000 shares of the stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $25.62, for a total transaction of $2,562,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Shares of CDLX stock traded down $0.46 during trading on Tuesday, hitting $25.09. The company had a trading volume of 245,800 shares, compared to its average volume of 222,782. The company has a current ratio of 2.37, a quick ratio of 2.37 and a debt-to-equity ratio of 0.99. The stock has a market cap of $574.41 million, a price-to-earnings ratio of -11.72 and a beta of 1.77. Cardlytics Inc has a 52 week low of $9.80 and a 52 week high of $28.29.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.30) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.61) by $0.31. The company had revenue of $35.99 million for the quarter, compared to analysts’ expectations of $36.11 million. Cardlytics had a negative net margin of 25.53% and a negative return on equity of 84.02%. Cardlytics’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.35) earnings per share. As a group, sell-side analysts forecast that Cardlytics Inc will post -1.21 EPS for the current fiscal year.

Several hedge funds have recently bought and sold shares of the stock. Marshall Wace LLP bought a new position in shares of Cardlytics in the first quarter worth approximately $336,000. FMR LLC grew its position in Cardlytics by 2.3% during the first quarter. FMR LLC now owns 3,284,572 shares of the company’s stock valued at $54,327,000 after acquiring an additional 72,847 shares during the last quarter. ExodusPoint Capital Management LP bought a new position in Cardlytics during the first quarter valued at approximately $185,000. Cannell Capital LLC grew its position in Cardlytics by 23.7% during the first quarter. Cannell Capital LLC now owns 626,975 shares of the company’s stock valued at $10,370,000 after acquiring an additional 119,957 shares during the last quarter. Finally, Wellington Management Group LLP grew its position in Cardlytics by 97.1% during the first quarter. Wellington Management Group LLP now owns 391,802 shares of the company’s stock valued at $6,481,000 after acquiring an additional 193,050 shares during the last quarter. Institutional investors own 73.51% of the company’s stock.

A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of Cardlytics from a “hold” rating to a “buy” rating and set a $21.00 price target on the stock in a report on Wednesday, March 6th. ValuEngine cut shares of Cardlytics from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, April 23rd. SunTrust Banks restated a “buy” rating and issued a $25.00 price objective on shares of Cardlytics in a research report on Wednesday, March 6th. Finally, KeyCorp upped their price objective on shares of Cardlytics from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Friday, May 10th. Eight investment analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and an average target price of $22.71.

TRADEMARK VIOLATION NOTICE: “Cardlytics Inc (NASDAQ:CDLX) Major Shareholder Sells $2,562,000.00 in Stock” was reported by WKRB News and is owned by of WKRB News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.wkrb13.com/2019/06/12/cardlytics-inc-nasdaqcdlx-major-shareholder-sells-2562000-00-in-stock.html.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

See Also: How does inflation affect different investments?

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.